Male Breast Carcinoma — Trials

Male Breast Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

104 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4
Recruiting: 2
Ph III recruiting: 0
Growth YoY: —
Industry share: 0%
Top sponsor: H. Lee Moffitt Cancer Center and Research Institute
Termination share: 34%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (23)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT05501704	ETHAN - ET for Male BC	recruiting	Phase 2	60	Jose Pablo LeoneOTHER	1	Aug 24, 2026	clinicaltrials
NCT03384914	Vaccine to Prevent Recurrence in Patients With HER-2 Positive Breast Cancer	active not recruiting	Phase 2	119	H. Lee Moffitt Cancer Center and Research InstituteOTHER	1	Mar 6, 2026	clinicaltrials